🧬 Thrilled to share our new publication in Molecular Metabolism!
Our findings reveal a role of mitochondrial fusion in promoting lipid imbalance and vascular disease, suggesting that mitochondrial dynamics could be a novel therapeutic target in #CVD https://t.co/ZyCI95UOPw
📣 It’s spring time!
📆 6-8 April 2025
🎂 X edizione del meeting dedicato ai giovani ricercatori clinici e di base di #SISA#SIMI#SIIA#SID#SIPREC#SIGG.
Let’s meet, discuss, joint and enjoy!
https://t.co/8gMLMnqmq0
🚀 New Review Alert! 🚀
Targeting PCSK9 beyond the liver. PCSK9 is well known for its role in cholesterol metabolism, but emerging evidence suggests its impact extends beyond the liver. @DaniloNorata @AndreaBaragetti https://t.co/8c8la2IJEX
We are excited to share our latest research highlighting how neuronal PCSK9 influences synaptic ApoER2 localization, offering new insights into its role in the brain. https://t.co/lsHjbW01Ar @DaniloNorata@lore_ddlt
Let's give a big cheer for our scholarship award winners who joined us at the Trajectories to Heart Failure / Immunometabolism meeting in Keystone, CO, USA! To learn more about scholarships, visit https://t.co/OdRrmVWzo7. #keystonesymposia#keystoneconferences#scholarships
Proud of our team member @lore_ddlt for being Awarded with a scholarship at the #KSHeartFail25 on the role of mitochondrial metabolism in the interplay between heart and the liver! @KeystoneSymp! Many compliments to all the awardee!
The new manuscript from the lab and @AndreaBaragetti is out!!! Enjoy the read of Exploring neutrophils as therapeutic targets in cardiometabolic diseases: Trends in Pharmacological Sciences https://t.co/u4Mw2EIkTj
What a privilege to host such great group of clinicians and scientists at the Young Fellows of the @society_eas in Vienna. Thank you to all the participants and speakers!
What a blast😃! 🚀Great talk at @SIFfarmacologia congress 2024 Sorrento, held by @lore_ddlt regarding key role of OPA1 in heart metabolism. Tremendous job of @LabNorata 💪💪
The last review of the lab have been recently published! Are you interested in the therapeutic option to lower Lp(a)? Enjoy the read
@DaniloNorata@AndreaBaragetti @lorydad89
https://t.co/buA84C74AR